Literature DB >> 22250812

Allopurinol-induced palisaded neutrophilic and granulomatous dermatitis.

Katherine Gordon1, Maria Miteva, Daniele Torchia, Paolo Romanelli.   

Abstract

We describe a 64-year-old man with past chronic myeloid leukemia. Palisading neutrophilic granulomatous dermatitis of the hands was diagnosed and related to recent allopurinol intake. Allopurinol is known to rarely cause granulomatous reactions, but this appears to be the first case of palisading neutrophilic granulomatous dermatitis induction. Possible mechanisms include immune complex deposition, an immune response directed against the metabolites of allopurinol, or allopurinol hypersensitivity exclusively localized to the skin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22250812     DOI: 10.3109/15569527.2011.647180

Source DB:  PubMed          Journal:  Cutan Ocul Toxicol        ISSN: 1556-9527            Impact factor:   1.820


  4 in total

1.  Granulomatous Cutaneous Drug Eruptions: A Systematic Review.

Authors:  Nidhi Shah; Monica Shah; Aaron M Drucker; Neil H Shear; Michael Ziv; Roni P Dodiuk-Gad
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

Review 2.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

3.  Palisaded neutrophilic and granulomatous dermatitis associated with ledipasvir/sofosbuvir.

Authors:  Mary Elizabeth Reed Shenk; Kimberly Marie Ken; Kara Braudis; Kristen Heins Fernandez
Journal:  JAAD Case Rep       Date:  2018-09-14

4.  Palisaded neutrophilic and granulomatous dermatitis following a long-standing monoclonal gammopathy: A case report.

Authors:  Dorsa Zabihi-Pour; Bahar Bahrani; Dalal Assaad; Jensen Yeung
Journal:  SAGE Open Med Case Rep       Date:  2021-02-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.